
About Korea Biomedical Review
Korea Biomedical Review is a Media & Entertainment company based in Seoul (South Korea) founded in 2017. Biomedical review information is provided via an online platform. It operates on a Advertising Model model. Its chief executive, as recorded, is Yang Kyung Cheol. Its website koreabiomed.com draws about 63 thousand monthly visits. The company has since been acquired. Korea Biomedical Review offers products and services including KBR Online News Platform. Its focus areas include Media, Digital Media and Online News. Its legal entity is The Korean Doctors’ Weekly Co., Ltd.
Company details
Korea Biomedical Review is managed as a leading online news platform in South Korea, dedicated to the biomedical and healthcare industries. Coverage is provided across pharmaceuticals, biotechnology, medical devices, ICT, beauty, policy, hospitals, and life sciences. Detailed reporting is offered on industry trends, innovations, and regulatory updates. The platform serves as a key resource for professionals and stakeholders in the Korean and global healthcare markets. Content is curated to ensure timely and accurate information is disseminated to its audience.
- Headquarters Seoul, South Korea
- Stage Acquired
- SectorsMedia & Entertainment
- Email••••••••
- Phone•••• ••••
- Website koreabiomed.com
- Social LinkedIn X Facebook
- Legal Name The Korean Doctors’ Weekly Co., Ltd
- Investors
Products & Services of Korea Biomedical Review
Korea Biomedical Review offers a comprehensive portfolio of products and services, including KBR Online News Platform.
Online news platform covering biomedical industry updates.
Investors in Korea Biomedical Review
Korea Biomedical Review has secured backing from 1 investor. Prominent investors backing the company include Dx&Vx.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
No company activity is described on the website. | dxvx.com |
Investor details for Korea Biomedical Review
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Korea Biomedical Review
3 people are tracked at Korea Biomedical Review (3 in leadership).
| Name | Role | Group |
|---|---|---|
shim Hyun-tai | Leadership | |
Yang Kyung Cheol | CEO | Leadership |
Kim Chan-hyuk | News Author | Leadership |
Complete people profiles for Korea Biomedical Review
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Web traffic of Korea Biomedical Review
The website of Korea Biomedical Review (koreabiomed.com) receives about 62.6K visits a month.
- Monthly visits62.6K
▲ 27.4% vs previous month
Websites whose visitors overlap most with Korea Biomedical Review. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| medicaldialogues.in | 100% | 1.5M | #49,047 | View details | |
firstwordpharma.com | firstwordpharma.com | 99% | #237,108 | – | |
| ivxhealth.com | 89% | 33.4K | #903,729 | View details | |
vax-before-travel.com | vax-before-travel.com | 82% | #467,958 | – | |
| pharmacytimes.com | 82% | 495.5K | #125,424 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Korea Biomedical Review
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Korea Biomedical Review
Korea Biomedical Review was founded in 2017.
Korea Biomedical Review is headquartered in Seoul, South Korea.
Yang Kyung Cheol is the CEO of Korea Biomedical Review, as recorded in our data.
Korea Biomedical Review is managed as a leading online news platform in South Korea, dedicated to the biomedical and healthcare industries. Coverage is provided across pharmaceuticals, biotechnology, medical devices, ICT, beauty, policy, hospitals, and life sciences. Detailed reporting is offered on industry trends, innovations, and regulatory updates. The platform serves as a key resource for professionals and stakeholders in the Korean and global healthcare markets. Content is curated to ensure timely and accurate information is disseminated to its audience.
Korea Biomedical Review offers KBR Online News Platform.
Korea Biomedical Review has 1 investor. Key investors include Dx&Vx.
Korea Biomedical Review operates through The Korean Doctors’ Weekly Co., Ltd.